Login / Signup

Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model.

Chiao-Fang TengTing WangTzu-Hua WuJia-Hui LinFu-Ying ShihWoei-Cherng ShyuLong-Bin Jeng
Published in: Therapeutic advances in medical oncology (2020)
Our data suggested that combination therapy with DC vaccine and PD-L1 inhibitor might have great promise as a novel treatment strategy for HCC.
Keyphrases
  • combination therapy
  • dendritic cells
  • mouse model
  • big data
  • regulatory t cells
  • electronic health record
  • immune response
  • replacement therapy